MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development

Published:2018-02-13 Issue:1 Volume:37 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Xie Xingwang,Wang Xueyan,Liao Weijia,Fei Ran,Wu Nan,Cong Xu,Chen Qian,Wei Lai,Wang Yu,Chen Hongsong

Funder

The National Natural Science Foundation of China

The National Key Sci-Tech Special Project of China

The Beijing Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-018-0693-7.pdf

Reference31 articles.

1. Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9(10):749–58.

2. Fujimoto A, Furuta M, Totoki Y, Tsunoda T, Kato M, Shiraishi Y, Tanaka H, Taniguchi H, Kawakami Y, Ueno M, et al. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat Genet. 2016;48(5):500–9.

3. Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997;420(1):25–7.

4. Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature. 1995;378(6553):203–6.

5. Riley MF, Lozano G. The many faces of MDM2 binding partners. Genes & cancer. 2012;3(3–4):226–39.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on the expression and prognostic relationship of MYL6B in liver cancer based on bioinformatics;World Journal of Clinical Oncology;2024-09-24

2. circ_0114866 promotes the progression and EMT of non-small cell lung cancer via miR-653-5p/MYL6B axis;Heliyon;2024-09

3. Identification of a novel sepsis prognosis model : Based on transcriptome and proteome analysis;Shock;2024-06-12

4. Seizure enhances SUMOylation and zinc-finger transcriptional repression in neuronal nuclei;iScience;2023-09

5. Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen;Journal for ImmunoTherapy of Cancer;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3